Active SanctionorganizationID: tw-shtc-392756af8f9877b1b328f6d80b33f07f755d689b

Mainpharma

Primary Source
TW SHTC
Coverage
sy
Risk Tier
Critical
Last Updated
2026-07-26

Compliance Profile

"Risk Warning: Confirming the inclusion of Mainpharma (Entity) in global watchlists, including TW SHTC. Transactions or engagement may require review."

Banking Impact

Due to designation on TW SHTC, processing any financial operations for this counterparty poses severe compliance risks, including secondary sanctions and asset forfeiture.

Legal Status

Comprehensive compliance barriers prohibit routine business. Organizations must freeze associated economic resources and report findings to relevant authorities.

Official Source Metadata

Source: Global Sanctions
Full Legal NameMainpharma
Source Records
TW SHTC
Enforcement TypeGlobal Sanctions
Risk Topicssanction, export.control

Associated Subject Network

"Hassan Al-nabi
IL MOD CRYPTO
"Zayn Al-ustad
IL MOD CRYPTO
"Ківі Банк" (Акціонерне Товариство)
Акционерное общество "КИВИ"
UA NSDC SANCTIONS
'Abbas Katerji
US OFAC SDN

Compliance Context Review

Independent Risk Assessment

SIC Group prepares source-backed risk context, exposure memos, and remediation pathways for entities seeking to clarify a public record or counterparty signal.

Source-list verification
Banking and counterparty exposure memo
Regulatory status and remediation triage
Request Risk Assessment
Confidential Review
Export PDFSubscriber Only